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on the cell membrane. This multivalent 
binding highly increases the nanomate-
rial’s overall avidity,[3] which is why over 
the last years the research focus has been 
set on improving this trait. Still, targeted 
nanomaterials fail to achieve optimal 
results and studies deliver highly variable 
outcomes. This can mainly be attributed 
to an incomplete understanding of the 
influence that distinct particle design fea-
tures have on multivalent interactions and, 
therefore, the particle’s fate after binding. 
Additionally, adjustment of one particle 
attribute usually correlates with modifica-
tions of several other characteristics, which 
highly influences the outcome at cellular 
level. Therefore, a profound understanding 
of the parameters affecting multivalent 
binding is needed to improve NP design.
There are several factors that are known 
to influence a nanomaterial’s multivalent 
binding, and thus the targeting capacity of 
NPs, such as particle size and receptor- or 
ligand density.[4,5] The latter not only deter-
mines the ability of a NP to bind to the 
target cell surface, but also the thermodynamic feasibility of cel-
lular uptake[6] and its precise pathway.[7] Still, there are several 
other elements that contribute to the thermodynamic favorability 
of a multivalent interaction, among which flexibility was noted to 
be crucial by several publications.[8,9] In their seminal theoretical 
paper, Kitov and Bundle highlight that the flexibility of a system 
significantly increases the number of ways in which bonds can 
be formed in a multivalent interaction which, in turn, supports 
binding.[10] More so, they predict the compensation of the entropy 
loss derived from a binding by an increase in possible conforma-
tions and a reduced steric burden.[10] Therefore, a higher flex-
ibility in a particle system that allows for a higher ligand mobility 
could enhance cellular interaction. However, ligand mobility on 
the particle corona is not sufficiently taken into consideration 
in particle design. Furthermore, the interplay between ligand 
mobility and ligand density is not yet completely understood.
NPs are commonly shielded by polymers, such as 
poly(ethylene glycol) (PEG), which, beside acting as a tether 
for ligands, enable prolonged circulation times[11] and reduce 
plasma protein absorption.[12] To achieve those effects, a high 
polymer surface density is usually required,[13] which restrains 
the flexibility of the system and the ligand mobility. Generally, 
the polymers comprising the NP corona are kept homoge-
neous in terms of length, i.e., molecular weight, and the multi-
valent interactions are to some extent length-dependent.[14] For 
Multivalent nanoparticle binding to cells can be of picomolar avidity making 
such interactions almost as intense as those seen with antibodies. However, 
reducing nanoparticle design exclusively to avidity optimization by the choice 
of ligand and its surface density does not sufficiently account for controlling 
and understanding cell–particle interactions. Cell uptake, for example, is of 
paramount significance for a plethora of biomedical applications and does not 
exclusively depend on the intensity of multivalency. In this study, it is shown 
that the mobility of ligands tethered to particle surfaces has a substantial 
impact on particle fate upon binding. Nanoparticles carrying angiotensin-II 
tethered to highly mobile 5 kDa long poly(ethylene glycol) (PEG) chains sepa-
rated by ligand-free 2 kDa short PEG chains show a superior accumulation in 
angiotensin-II receptor type 1 positive cells. In contrast, when ligand mobility 
is constrained by densely packing the nanoparticle surface with 5 kDa PEG 
chains only, cell uptake decreases by 50%. Remarkably, irrespective of ligand 
mobility and density both particle types have similar EC50 values in the 
1–3 × 10−9 m range. These findings demonstrate that ligand mobility on the 
nanoparticle corona is an indispensable attribute to be considered in particle 
design to achieve optimal cell uptake via multivalent interactions.
1. Introduction
Nanoparticles (NPs) are considered ideal candidates for drug 
delivery because they are able to convey their cargo to a desired 
site of action, thus avoiding the deleterious consequences of off-
target effects.[1] To achieve specific NP–cell interactions, particle 
surfaces are usually functionalized with ligands that are able 
to recognize distinct cellular structures. To counterbalance the 
affinity loss derived from the tethering of ligands to linkers,[2] 
numerous ligand molecules are coupled to a single NP to enable 
the simultaneous recognition of several receptor molecules 
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example, it was demonstrated that decreasing the overall PEG 
length can increase the uptake of liposomes[15] and polymer 
NPs.[16] However, these adjustments in polymer composition can 
reduce the overall particle PEG covering. Concomitantly, they tre-
mendously alter particle size, which is a key factor determining 
NP–cell interactions,[17] making it difficult to discern which 
parameter contributed to the targeting increase. Therefore, the 
goal of this study was to investigate the effect of ligand mobility 
while maintaining a high PEG density and producing minor 
particle size variations. For our purposes we decided to design 
NPs with heterogeneous surface polymer compositions, a design 
choice sparsely represented in the literature.[15,18–21] To date, this 
concept is loosely associated with higher targeting efficiency 
or improved ligand binding and density control, but a deeper 
understanding of how it affects ligand mobility is required.
For our systematic investigation on the impact of ligand 
mobility on multivalent targeting particles, we relied on polymer 
NPs as a scaffold, consisting of PEG-poly(lactic acid)(PLA) and 
poly(lactic-co-glycolic acid) (PLGA). We considered them highly 
suited for this study as their ligand mobility can be tailored by 
adjusting the polymer composition. More so, they are biocompat-
ible and biodegradable and are fitted for the use as drug carriers. 
To endow particles with targeting capacities we used angiotensin 
derivative ligands, which we previously used for highly specific 
cell identification,[22] and sought to further improve the system 
by adjusting its flexibility. To that end, we coupled angiotensin-
I (Ang-I) or angiotensin-II (Ang-II), targeting cell membrane-
bound angiotensin converting enzyme (ACE) or angiotensin-
II type 1 receptor (AT1R), respectively, to long PEG5k-PLA10k 
chains and kept the remaining nonmodified polymers (NMPs) 
shorter by using a PEG2k–PLA10k to allow higher conformational 
freedom to the ligand-carrying polymers (LMPs) (Figure 1a). 
We compared this “flexible” NP-design with particles carrying 
NMPs of the same length as the LMPs, representing the conven-
tional NP formulations. Additionally, we manufactured particles 
with increasing ligand densities to investigate if higher targeting 
capability (more ligands) would compensate for the associated 
mobility loss. The resulting NP formulations were characterized 
Macromol. Biosci. 2020, 1900427
Figure 1. Composition a) and characterization of Ang-II b–d) and Ang-I e–g) targeted NP formulations. Hydrodynamic diameter measured by DLS 
b,e), ξ-potential c,f), and correlation of the measured normalized molar ligand content and the predicted ligand density d,g). Results are presented as 
mean ± SD of at least n = 3 measurements.
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in terms of size, surface charge, and ligand content. Their ligand 
affinity and particle avidity toward their respective targets were 
evaluated, and their cellular interaction regarding targeting effi-
ciency, uptake specificity, and cellular distribution was analyzed. 
Finally, the polymer conformation on the particle corona and the 
distance between ligands was estimated.
2. Results and Discussion
2.1. Ligand Decorated NPs
To study the effect of ligand mobility on the NP–cell interac-
tions, we chose polymeric PEG–PLA NPs with a PLGA-stabilized 
hydrophobic core, to avoid size increases resulting from a sta-
bilization with high molecular weight PLA.[23] Such NPs are 
well-known for their biocompatibility and high versatility, as 
the particle composition can be precisely tailored by combining 
different PEG–PLA block copolymers (Figure 1a). Additionally, 
they are readily prepared via bulk nanoprecipitation of organic 
polymer solutions in aqueous medium. We covalently coupled 
ligands to longer carboxylic acid-terminated PEG5k–PLA10k copol-
ymers prior to NP preparation (Figure S1, Supporting Informa-
tion), which allows for precise control of the ligand density on the 
NP corona. NMPs were either the same length as the LMPs with 
carboxylic acid-ended PEG5k–PLA10k (COOH–PEG5k–PLA10k) or 
a shorter COOH–PEG2k–PLA10k to create NPs with homo- or het-
erogeneous polymer shells (NP5/510 or NP2/510, respectively) with 
varying ligand densities (Figure S2, Supporting Information). To 
impart specific recognition ability to our NPs, we chose to use 
two peptidic ligands that target a receptor and/or a cell mem-
brane-bound enzyme, Ang-II and Ang-I, respectively. Ang-II is 
known for its high-affinity to the AT1R,[24] which upon binding is 
responsible for receptor-mediated endocytosis.[25] Ang-I is a sub-
strate for ACE,[26] which we recently used to develop highly spe-
cific virus-mimetic NPs.[22] The binding of Ang-I-decorated NPs 
to the cell membrane-bound ACE results in the excision of the 
last two amino acids of the peptide, generating Ang-II-carrying 
NPs that are internalized through AT1R-mediated endocytosis. To 
minimize any possible interference on the NP–cell interaction,[27] 
the polymers were chosen to keep the particles in a narrow size 
range (60–80 nm) (Figure 1b,e). The resulting particles carried 
a negative surface charge that decreased in absolute value with 
increasing ligand content on the particle surface (Figure 1c,f) 
due to decreasing numbers of carboxylic acid-terminated NMPs. 
Creating NPs with negative surface charges is a great method of 
avoiding nonspecific attachment to the negative cell membrane. 
To evaluate the effect of ligand density on the particle–cell inter-
action, NPs with low (20%), medium (40%), and high (80%) 
ligand densities were prepared. Since polymer-ligand coupling 
occurred prior to particle preparation, the predicted ligand den-
sity correlated well with the actual ligand density measured after 
particle preparation (Figure 1d,g).
2.2. AT1R-Binding of Ang-II Carrying NPs
To determine the effect that ligand mobility exerts on the AT1R 
interaction and the NP’s overall avidity, NP2/510 and NP5/510 
functionalized with Ang-II (NP2/510Ang-II and NP5/510Ang-II, 
respectively) carrying 20%, 40%, or 80% ligand densities were 
prepared. The affinities of the particle-bound ligands and 
avidities of the resulting formulations toward the AT1R after a 
short NP–cell contact were evaluated using a calcium mobiliza-
tion assay (Figure 2) with AT1R-expressing rat mesangial cells 
(rMCs),[22] as previously described by our group.[22,28] Under 
normal conditions, rMCs express high levels of the AT1R, of 
about 1185 ± 83 fmol mg−1 protein.[29] The stimulation of the 
Gq-coupled AT1R by an agonist results in a cytosolic Ca+2 influx 
that is measured by this assay.[25] It is known that the binding 
of ligands to polymers like PEG reduces their affinity toward 
their target receptor[2] (Figure S3a, Supporting Information). 
Interestingly, the coupling of Ang-II to COOH–PEG5k–PLA10k 
resulted in even higher affinity loss than that measured for 
the PEGylated form. However, this is compensated through 
an avidity gain of NPs prepared from the aforementioned 
polymer (Figure S3b, Supporting Information), as they enable 
multivalent binding of the ligands to the cell membrane-bound 
receptors. The avidity of the particles (determined through 
the EC50 values obtained based on particle concentration 
(PNC-EC50)), was in the same nanomolar range for both par-
ticle types (Figure 2). However, there were notable differences 
between the two formulations regarding the effect of ligand 
density. While the avidity of NP2/510 significantly increased with 
higher functionalization (Figure 2a), it remained constant for 
NP5/510 (Figure 2b), even though the number of ligands per 
NP increased with the ligand density in both particle types 
(Figure S4, Supporting Information). This suggests that the 
rigid composition due to long NMPs of NP5/510 hinders subse-
quent ligand–receptor interactions with increasing numbers of 
available ligands. This is reinforced by the fact that the overall 
affinity of the particle-bound ligands (LC-EC50) remained equal 
independent of the NP composition (Figure 2c,d). As the only 
parameter affecting multivalency varied between the formula-
tions is the ligand mobility, the differences in avidity of NP2/510 
is most likely a result of the shorter NMPs.
However, in these experiments the NP–cell contact is very 
brief (under 1 min). As NPs are much larger than free ligands, 
they experience diminished diffusion, and thus require an 
extended presentation time to effectively interact with their 
targets. To investigate NP–cell interactions over a longer time-
scale, specifically how the avidity of NP2/510Ang-II for the AT1R 
is affected, we extended the incubation period of the NPs with 
cells to 30 min (Figure 3) and determined the NP avidity (PNC-
IC50) (Figure 3a) and the particle-bound ligand affinity (LC-
IC50) (Figure 3b). After extensive NP–cell contact, the avidity 
of NP2/510Ang-II increased (Figure 3a). However, this increase 
was only significant for particles with low (20%) ligand den-
sities, i.e., highest ligand mobilities (Figure 3a). The particle-
bound ligands also displayed increased affinities (IC50) for the 
AT1R compared to the ones obtained after a short stimulation 
(EC50) (Figure 3b) and the highest increase was also seen for 
NP2/510 at low ligand densities (20%) (Figure 3b). These results 
indicate that a higher ligand mobility leads to a slower NP–
cell interaction which can be explained by a lower number of 
ligands on the particle corona,[6] which necessitate extra time 
to execute binding. Additionally, reversible entrapment of the 
ligands in the polymer chains may occur,[30] impairing rapid 
Macromol. Biosci. 2020, 1900427
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ligand–receptor interactions. This phenomenon is more prob-
able in NPs with low grafting densities[31] and long polymer 
chains.[32] The slower interactions of flexible particles may 
show potential benefits in vivo where NPs face extensive cir-
culation times and, more importantly, off-target cells. As the 
selectivity of a multivalent system can be increased if initial 
binding is impeded by a repulsive factor,[9] the delayed initial 
binding of particles with high ligand mobility (NP2/510 20% 
ligand) (Figures 2 and 3) may be an alternative to the suggested 
approach of adding sterically hindering polymer chains.[33] 
Additionally, the inclusion of extra polymers, which can hinder 
the subsequent targeting efficiency, would be circumvented by 
this design. However, this needs to be further investigated in 
future experiments.
Macromol. Biosci. 2020, 1900427
Figure 3. Influence of the AT1R stimulation period on the particle avidity a) and particle-bound ligand affinity b) of NP2/510Ang-II. A short (1 min) 
direct stimulation of rMCs with the particles yields a dose response curve where the EC50 values can be calculated. By preincubating the cells with the 
NPs (30 min) and treating them afterward with free Ang-II, the IC50 values can be determined. Results are presented as mean ± SD of at least n = 3 
measurements. Levels of statistical significance are indicated as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, and ****p ≤ 0.0001, and #p ≤ 0.05 compared to 
particle-bound ligand affinity at 40% ligand density n.s: nonsignificant.
Figure 2. AT1R stimulation by Ang-II decorated NPs in rMCs. Maximum intracellular calcium response of NP2/510Ang-II a) and NP5/510Ang-II b) with 
different ligand densities. Particle avidity and ligand affinity of NP2/510Ang-II c) and NP5/510Ang-II d). PNC-EC50 (EC50 values calculated based on NP 
concentration); LC-EC50 (EC50 values calculated based on particle-bound ligand concentration). Results are presented as mean ± SD of at least n = 3 
measurements. The data in (c) are fitted with a second-order polynomial. Levels of statistical significance are indicated as *p ≤ 0.001 comparing PNC-
EC50 values at different ligand densities.
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2.3. ACE Kinetics Using Ang-I Decorated NPs as Substrates
To explore the effect of ligand availability on the multiva-
lent binding abilities toward an alternative target, we selected 
Ang-I-decorated NPs that interact with the cell membrane-
bound ACE.[22] NPs with 20%, 40%, or 80% Ang-I modified 
PEG5k–PLA10k were prepared, with particle coronas made up 
of either short COOH–PEG2k–PLA10k or long COOH–PEG5k–
PLA10k NMPs (NP2/510Ang-I and NP5/510Ang-I, respectively). 
Soluble ACE obtained from rabbit lung served as a surrogate 
for the cell membrane-bound form of the enzyme to deter-
mine the Michaelis–Menten kinetics for the different particles 
(Figure 4). The Michaelis–Menten constant (Km) was calcu-
lated based on the ligand (Figure 4a,b) and particle concentra-
tions (Figure 4c,d) for the different NP formulations (Table S1, 
Supporting Information). Additionally, the catalysis constant 
(Kcat) was determined to calculate the specificity constant 
(Kcat/Km), which is useful in comparing different substrates 
for the same enzyme[34] (Figure 4e,f). The substrate that yields 
the highest specificity constant is considered the best substrate 
for the enzyme. At all ligand densities, the Kcat/Km values for 
NP2/510 were significantly higher than those for NP5/510, for 
both ligand- (Figure 4e) and NP concentration-based (Figure 4f) 
calculations. This suggests that the ligands on their surface 
are better accessible to the enzyme, which can be attributed 
to the shorter NMPs. For both NP2/510 and NP5/510, the affinity 
for the enzyme increases with higher ligand density, probably 
due to a higher number of ligand molecules on the NP sur-
face (Figure S4, Supporting Information) that are able to bind 
more enzyme molecules. Nevertheless, because a soluble form 
of ACE was used for the experiments, the ligand-enzyme inter-
action is not spatially constrained as it would be with the cell 
membrane-bound enzyme and cannot fully illustrate the multi-
valent binding on a cellular surface.
2.4. Cellular Internalization of AT1R-Targeting NPs
To determine the influence of ligand mobility at a cellular 
level we performed uptake experiments (Figure 5) analyzed 
via flow cytometry (Figure 5a) and confocal laser scanning 
microscopy (CLSM) (Figure 5b). rMCs, positive for AT1R 
expression, were used as target cells.[22] Considerable differ-
ences could be detected between Ang-II decorated NP2/510 
and NP5/510. In agreement with our previous experiments, 
uptake was noticeably dependent on ligand density for 
NP2/510. However, lower ligand densities (20%) resulted in 
much better cellular internalization than medium- (40%) or 
high (80%) ligand densities, differing from what would be 
expected by the AT1R-avidity measurements performed at 
short stimulation periods (Figure 2). These divergencies can 
be explained by the fact that for NP uptake the cells are incu-
bated for longer time periods (45 min) with the NPs. As can 
be seen for the avidity measurements after a long stimulation 
(Figure 3), the avidity of the particles evens out at all ligand 
densities. Additionally, it can be attributed to differences in 
experimental setup, as uptake experiments are performed 
with adherent cells, mimicking physiological conditions, and 
for the avidity measurements cells must be placed in suspen-
sion. Under such nonrestrictive conformational conditions, 
Macromol. Biosci. 2020, 1900427
Figure 4. Michaelis–Menten kinetics of Ang-I decorated NPs. Enzyme kinetics calculated based on ligand concentrations of NP2/510Ang-I a) and 
NP5/510Ang-I b), or NP concentrations of NP2/510Ang-I c) and NP5/510Ang-I d) at different ligand densities. Specificity constant (Kcat/Km) of NP2/510 and 
NP5/510 calculated with the e) ligand- or f) NP concentration-based Km. Results are presented as mean ± SD of at least n = 3 measurements. Levels 
of statistical significance are indicated as *p ≤ 0.05 comparing NPs with 80% ligand density to NPs with 20% or 40% ligand density and #p ≤ 0.005 
comparing NP2/510 and NP5/510.
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receptor interactions at higher ligand densities may be 
favored.
NP5/510-associated fluorescence was independent of the 
degree of functionalization, mirroring the AT1R avidity meas-
ured by the intracellular calcium assay described above. This 
indicates that a lower ligand mobility constrains the ligand–
receptor interaction. When rMCs were incubated with an AT1R 
antagonist, losartan carboxylic acid (EXP3174), for 30 min, we 
observed significant suppression of uptake which suggests spec-
ificity. Overall, NP2/510 were taken up to a much higher extent 
than NP5/510, demonstrating that shorter 2k NMPs that enhance 
the ligand mobility facilitate the NP–cell interaction. It points 
toward a better receptor binding, as higher internalization 
rates are usually related to enhanced multivalent binding.[35] 
With 80% ligand density, the uptake of NP2/510 matches that of 
NP5/510, as the particles assimilate, and the ligands lose mobility 
due to an increase in long LMPs. At 80% ligand density, 80% of 
the PEG on the particle surface is long 5k PEG, and only the 
remaining 20% is the shorter 2k for NP2/510 or longer 5k PEG 
for NP5/510. With this polymer composition, it seems that the 
favorable effects of shorter NMPs are lost, as there are majority 
of longer polymer chains hindering the ligand binding. These 
results highlight the importance of ligand mobility to obtain 
satisfactory cellular interaction. Contrary to common assump-
tions that increasing the degree of functionalization increases 
the targeting potential of NPs, here we demonstrate that the 
amount of ligand present on the surface is not as important as 
its mobility, i.e., the conformational flexibility that allows it to 
interact with the target receptors. Similar effects were described 
by Poon et al. for folate-functionalized particles. They noticed 
that increasing the surface coverage over the optimal 20% 
lead to less efficient NP uptake.[36] Furthermore, an increase 
in ligand density usually reduces the targeting potential due 
to enhanced serum protein adsorption resulting from covering 
the PEG shield with ligands. Minimizing protein corona for-
mation is essential to preserve the specific targeting abilities of 
Macromol. Biosci. 2020, 1900427
Figure 5. Cellular internalization of NP2/510Ang-II and NP5/510Ang-II in rMCs. Uptake of NPs with different ligand densities and uptake inhibition by 
free EXP3174 analyzed by flow cytometry a). Uptake of NP2/510Ang-II and NP5/510Ang-II with 20% or 80% ligand density analyzed by CLSM (Scale bar 
20 µm) b). Internalization inhibition of NP2/510Ang-II c) and NP5/510Ang-II d) by chlorpromazine (ChP), genistein (GEN), or cytochalasin D (CyD). 
Results are presented as mean ± SD of at least n = 3 measurements. Levels of statistical significance are indicated as **p ≤ 0.005, ***p ≤ 0.0005, and 
****p ≤ 0.0001. n.s.: nonsignificant.
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nanomaterials[37] and avoid their clearance by macrophages.[38] 
For our formulations, significantly higher serum protein 
adsorption was observed for rigid NP5/510 compared to flex-
ible NP2/510 (Figure S5, Supporting Information). This seems 
to corroborate our assumption that LMPs on flexible particles 
can assume a partially folded conformation, which initially may 
shield the ligand. This trend is enhanced with lower particle 
functionalization.
Intracellular localization of the NPs was confirmed by CLSM 
analysis (Figure 5b). For microscopy experiments, only par-
ticles with low (20%) and high (80%) ligand densities were 
investigated. NPs with medium (40%) ligand density were not 
examined because minor differences between particle types are 
difficult to discern by this method. The results mirrored those 
obtained by flow cytometry. The highest NP-associated fluores-
cence was seen for NP2/510 with 20% ligand on the surface. At 
80% ligand density, uptake of NP2/510 is comparable to that of 
NP5/510, which shows no dependency with the ligand density. 
The uptake could be inhibited by EXP3174 treatment of cells 
prior to NP addition (Figure S6, Supporting Information).
To investigate if ligand mobility influences the internaliza-
tion pathway of Ang-II functionalized NPs, we performed 
uptake inhibition studies by preincubating the cells with 
either chlorpromazine, genistein, or cytochalasin D (clathrin, 
caveole, or actin polymerization inhibitors, respectively) prior 
to NP addition. As shown in Figure 5c,d, adding chlorproma-
zine significantly inhibited uptake of Ang-II carrying NPs 
by about 60–80%. This level of inhibition was similar to that 
caused by EXP3174, indicating that particles are mainly taken 
up by specific clathrin-mediated endocytosis. We previously 
found the same uptake pathway for Ang-II decorated quantum 
dots.[28] Genistein did not affect NP uptake, indicating that it 
is not caveolae-mediated. As expected, Cytochalasin D caused 
the highest uptake inhibition, as it is able to inhibit both non-
specific particle uptake as well as interfere with other endocytic 
routes like clathrin-mediated endocytosis by disrupting the 
cell cytoskeleton.[39,40] Regarding the internalization route, no 
differences could be detected between the different formula-
tions, indicating that increased ligand mobility just enhances 
the multivalent binding of the receptor, without changing the 
natural endocytic route.
2.5. Cellular Internalization of Ang-I Decorated NPs
To determine the influence of ligand mobility on the uptake 
of enzyme targeting particles, we also determined the cellular 
uptake of ACE-targeting Ang-I decorated NPs (NP2/510Ang-I 
and NP5/510Ang-I) (Figure 6), via flow cytometry (Figure 6a) and 
CLSM (Figure 6b) in rMCs.[22] Ang-I is a substrate for ACE and 
when it is located on the particle corona it binds to the enzyme 
on the cell membrane. This results in the production of Ang-II 
on the particle surface and the NPs can then be internalized 
by AT1R-mediated endocytosis.[22] Interestingly, the uptake 
results for Ang-I decorated NPs mirrored the results for Ang-II 
decorated NPs. Higher uptake was obtained for NP2/510 com-
pared to NP5/510, which decreased with increasing ligand den-
sity. The specificity of uptake via the AT1R was proven by the 
significant suppression observed after addition of captopril, an 
ACE inhibitor (Figure 6a). The similarity between the uptake of 
Ang-I and Ang-II decorated NPs indicates that the initial con-
version of Ang-I on the particle surface is not a limiting factor 
for particle internalization. Furthermore, when comparing the 
uptake kinetics of Ang-I and Ang-II decorated NPs, equivalent 
results were obtained (Figure 6c,d). Because the enzymatic con-
version of Ang-I to Ang-II occurs rapidly on the rMC surface 
(2 pmol min−1),[22] it does not limit cellular uptake as much as 
multivalent AT1R binding. Under these experimental condi-
tions, the Ang-I on the particle surface is converted to Ang-II in 
less than 1 min by the cells. With a 45 min incubation period, 
this leaves the particles enough time to interact with the AT1R. 
Additionally, the higher uptake of Ang-I modified NP2/510 
is favored by the higher affinity of the ligands to the enzyme 
(Figure 4), which keeps them at the cell surface facilitating sub-
sequent receptor binding. Equivalent results were obtained by 
CLSM analysis (Figure 6b; and Figure S7, Supporting Informa-
tion), which confirmed intracellular localization of NPs.
2.6. Polymer Distribution on the NP Shell: Conformational 
Considerations and Distance between PEG Chains
To explain the differences between the NP formulations 
regarding interaction with their targets, we estimated the dis-
tance between the PEG chains on the particle corona. The theo-
retical distance between the polymer chains on a particle corona 
for a known NP diameter and polymer molecular weight can be 
calculated assuming that all the PEG from the PEG-PLA block-
copolymer migrates to the outer NP shell and the PLA blocks 
are anchored in the core[12] (see the Experimental Section for 
an exact explanation of the calculation). In this way we deter-
mined the distance between NMPs (ds), LMPs (D), and LMPs 
and the next same-length polymer (Ds) (Figure 7; and Table S2, 
Supporting Information). The ds values for NP2/510 and NP5/510 
are comparable, as the total polymer in both formulations is 
the same and increases with the ligand density (Figure 7b). D 
also follows the same trend for the two NP formulations, with 
decreasing distances at higher LMP content (Figure 7c). Never-
theless, when Ds is calculated, significant differences between 
the two NP species are detected (Figure 7d). For NP5/510, Ds 
remains constant, independent of the amount of ligand that 
the particles carry, because all the polymer chains are exactly 
the same length. For NP2/510, there is a significant decrease in 
Ds as more, longer LMP chains are added to the formulation. 
Furthermore, there is a significantly higher Ds for all ligand 
densities compared to NP5/510, due to the shorter NMPs. This 
indicates that the ligands have higher mobility freedom and 
are less sterically hindered on NP2/510 than on NP5/510. As the 
particles assimilate to NP5/510 at higher ligand densities this 
distance diminishes, and the particles become more rigid. 
Depending on the size of the target receptor or enzyme, the dis-
tance between ligands can highly influence the outcome of an 
interaction, as not all ligands may be able to bind. According 
to Erickson, the approximate radius of a protein in nm can be 
calculated assuming a spherical shape and an average specific 
volume of 0.73 cm3 g−1.[41] The AT1R is a protein composed 
of 359 amino acids with a molecular weight of ≈41 kDa.[42] 
The ACE has a molecular weight of 112 kDa.[43] Under the 
Macromol. Biosci. 2020, 1900427
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aforementioned assumptions, the diameters of the AT1R and 
ACE would be ≈4.6 and 6.4 nm, respectively. According to this, 
only the flexible particles (NP2/510) with low ligand density 
would be able to bind several targets in a multivalent manner 
(Figure 7d). At higher degrees of functionalization, the distance 
between consecutive ligands is smaller than the one between 
targets, leading to inefficient binding where some ligands may 
lose their targeting capacity and sterically hinder each other. 
For rigid NPs (NP5/510), the long NMPs can also limit the LMP 
mobility and prevent the ligands from interacting with their tar-
gets. This explains the superior NP–cell interaction displayed 
by NP2/510 (Figures 5 and 6), where the ligands have a higher 
conformational freedom to bind their targets, a trait conferred 
by the shorter NMPs. To further confirm the arrangement of 
the PEG chains on the particle surface, the Flory radius (RF) 
was calculated. If the distance between polymer chains is 
greater than RF, the polymers assume a folded mushroom 
configuration. When RF is greater than the distance between 
polymer chains, they adopt an extended brush conformation.[30] 
The RF values calculated for the 2k and 5k PEGs were 3.60 
and 6.06 nm. For all NP formulations, the distances between 
the PEG chains on the particle surface were less than the RF 
(Figure S8, Supporting Information), suggesting a brush con-
formation. For the low ligand density NP2/510 the distance 
between LMPs is over the RF value of 2k PEG but under that for 
5k PEG. Taken all together, this can explain the higher mobility 
and flexibility of the LMPs at lower ligand densities in NP2/510, 
for which there could be a partially folded configuration that 
would make interactions of such particles slower but more effi-
cient regarding binding and its subsequent cellular uptake.
3. Conclusion
The establishment of multivalent interactions between NPs and 
their target cells is a complex multifactorial process. Different 
particle attributes, such as size or ligand- type and density[5] 
are essential for determining the binding avidity. However, 
our work suggests that a high particle avidity for the targeted 
receptors does not unequivocally predict a particle’s fate after 
binding.
In this study, we demonstrated that by tailoring the polymer 
composition on the particle corona, the ligand mobility, and in 
turn the cellular uptake of NPs can be modulated. By combining 
Macromol. Biosci. 2020, 1900427
Figure 6. Cellular internalization of NP2/510Ang-I and NP5/510Ang-I in rMCs. Cellular uptake of NPs with different ligand densities and internalization 
inhibition by 1 × 10−3 m captopril analyzed by flow cytometry a). Uptake of NP2/510Ang-I and NP5/510Ang-I with 20% or 80% ligand density analyzed by 
CLSM (Scale bar 20 µm) b). Internalization kinetics of Ang-I c) or Ang-II d) functionalized NP2/510 and NP5/510 with 20% ligand density. Results are pre-
sented as mean ± SD of at least n = 3 measurements. Levels of statistical significance are indicated as **p ≤ 0.005, ***p ≤ 0.0005, and ****p ≤ 0.0001.
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polymers of different lengths, we were able to design particles 
with high polymer density, which is essential for stealth prop-
erties,[44] while still preserving the mobility of the tethered 
ligands. We showed that flexible particles (NP2/510) with the 
highest ligand mobility (at 20% ligand density) even though 
partially subjected to ligand shrouding have analogous avidi-
ties for their targets to their rigid counterparts (NP5/510) which 
present more surface-available but sterically hindered ligands. 
More so, after extensive cellular contact the interactions with 
the targets are facilitated and thus, the particles’ avidities and 
particle-bound ligand affinities significantly increased. Further-
more, flexible particles experience increased cellular uptake due 
to the optimal distance between targeting entities along with 
a higher ligand mobility. Interestingly, increasing the ligand 
density did not result in higher targeting ability of the NPs, 
due to a sterically hindered, inefficient target binding. Thus, it 
is advisable to avoid overloading NPs with ligands, which can 
potentially lead to less selective binding,[8,9] and instead adjust 
the ligand mobility. The initial ligand shrouding should be fur-
ther investigated, as it may have the potential to reduce initial 
binding, a strategy suggested to increase particle selectivity.[9,33] 
In this regard, the relationship of the formulation’s avidity and 
binding with the receptor density would need to be elucidated. 
It is reasonable to believe that higher receptor densities may 
lead to increased cellular interactions. A phenomenon height-
ened the more flexible the formulations is, as the number of 
possible bindings increases.[8]
Taken together, our results show that designing of multiva-
lently-binding NPs is an intricate process which necessitates 
finding a balance between several particle attributes. Among 
them, we show that the ligand mobility, which can be increased 
by adjusting the polymer corona composition and the number 
of targeting entities on the particle surface, needs to be consid-
ered to achieve optimal interactions at the cellular level.
4. Experimental Section
Materials: Carboxylic acid end-functionalized hydroxyl-PEG with 
molecular weights of 2000 (COOH–PEG2k–OH) and 5000 Da (COOH–
PEG5k–OH) were obtained from JenKem Technology USA Inc. (Allen, 
TX). Lysine N-modified Angiotensin-I (Lys-Ang-I) and Ang-II (Lys-Ang-II) 
(purity > 98%) were purchased from Genscript (Piscataway, NJ). EXP3174 
was purchased from Santa Cruz Biotechnology (Dallas, TX). Fura-2AM 
was purchased from Life Technologies (Carlsbad, CA). CellMask deep 
red plasma membrane stain (CMDR), and Pierce bicinchoninic acid 
(BCA) assay kit were purchased from Thermo Fisher Scientific (Waltham, 
MA). ACE from rabbit lung and all other reagents in analytical grade 
were obtained from Sigma-Aldrich (Taufkirchen, Germany). Ultrapure 
water was obtained from a Milli-Q water purification system (Millipore, 
Billerica, MA).
Cell Culture: rMCs were kindly gifted by Prof. Armin Kurtz (Institute 
of Physiology, University of Regensburg, Germany). They were 
cultured in RPMI1640 medium with 10% fetal bovine serum (Biowest, 
Nuaillé, France) supplemented with insulin-transferrin-selenium (Life 
Technologies, Carlsbad, CA) and 100 × 10−9 m hydrocortisone. The 
characterization of the cells for their AT1R and ACE expression was 
previously shown by the group.[22]
Polymer Synthesis and Ligand Coupling: PEG–PLA block-copolymers 
were synthesized via ring opening polymerization of cyclic lactide 
after Qian et al.[45] with slight modifications described previously by 
Figure 7. Distance between polymer chains on the NP corona at different ligand densities. Schematic representation of the distance among polymer 
chains on NP2/510 and NP5/510 a). Distance ds between NMPs b), distance D between ligand-modified polymer chains c) and distance Ds between 
ligand-modified polymer and the same length PEG chains d). Results are presented as mean ± SD of at least n = 3 calculations derived from at least 
n = 3 independent size measurements. The data in (d) were fitted with a second-order polynomial. Levels of statistical significance are indicated as 
*p ≤ 0.0001 comparing NP2/510 with 20%, 40%, and 80% ligand densities and #p ≤ 0.0001 comparing NP2/510 and NP5/510 at different ligand densities.
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the group.[46] COOH–PEG–OH was used as a macroinitiator and 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as a catalyst. Resulting 
polymers were 10 kDa PLA with either a 2 or 5 kDa carboxylic acid 
terminated PEG chain (COOH–PEG2k–PLA10k or COOH–PEG5k–PLA10k, 
respectively).[22]
To synthesize Ang-I/II-PEG5k–PLA10k, COOH–PEG5k–PLA10k (14 µmol) 
was activated with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide and 
N-Hydroxysuccinimide (350 µmol) in N,N-Dimethylformamide (DMF) 
for 2 h under stirring. Afterward, 2-Mercaptoethanol (863 µmol) was 
added to quench the reaction for 20 min. Either Lys-Ang-I or Lys-Ang-II 
ligand (17 µmol) were dissolved in DMF with N,N-Diisopropylethylamine 
(66 µmol), added dropwise to the activated polymer, and left to stir for 
48 h. The resulting polymer was diluted in Millipore water so that the 
DMF content was lower than 10% v/v and dialyzed using a 6–8 kDa 
molecular weight cut-off regenerated cellulose dialysis membrane 
(Spectrum Laboratories, Inc, Rancho Dominguez, CA) for 24 h (with 
medium change after 30 min, 2, and 6 h) to remove uncoupled ligand 
and reagents. To determine the degree of ligand modification, polymer 
micelles were created by precipitating ACN-dissolved polymer in 
Millipore water under stirring to a final concentration of 1 mg mL−1. 
After the complete evaporation of the organic phase, a Pierce BCA assay, 
following the manufacturer’s instructions, and an iodine complexing 
colorimetric assay,[47] as previously described,[16] were performed to 
quantify the ligand and PEG concentration, respectively (Figure S1, 
Supporting Information).
NP Preparation: For preparation of block copolymer NPs, 10 mg mL−1 
of either COOH–PEG2k–PLA10k or COOH–PEG5k–PLA10k (for NP2/510 or 
NP5/510, respectively) and PLGA13.4k were mixed in ACN at a 70:30 mass 
ratio. NPs were prepared via bulk nanoprecipitation under vigorous 
stirring in 10% Dulbecco’s phosphate buffered saline (DPBS) v/v 
(pH 7.4) to a final concentration of 1 mg mL−1. The NPs were left stirring 
for 3 h until the organic solvent was completely evaporated. Afterward, 
they were concentrated using a 30 kDa molecular weight cut-off 
Microsep advance centrifugal device (Pall Corporation, Port Washington, 
NY) at 959 g for 20 min. For particles with different ligand densities, 
the unmodified carboxylic acid-ended polymers were replaced by varying 
amounts of Ang-I/II-PEG5k–PLA10k, keeping the molar ratio of PEG 
chains to PLGA constant. For fluorescently-labeled NPs, a CF647- (for 
flow cytometry analysis) or TAMRA- (for CLSM experiments) covalently 
labeled PLGA, synthesized as described before by the group,[16] was used 
for NP preparation.
NP Characterization: Size and ξ-potential of all NP formulations 
were measured using a Malvern ZetaSizer Nano ZS (Malvern 
Instruments GmbH, Lappersdorg, Germany) with a 633 nm He-Ne 
laser at a backscatter angle of 173°. Size was measured in disposable 
microcuvettes (Brand, Wertheim, Germany). Electrophoretic mobility 
was measured using a folded capillary cell (Malvern, Herrenberg, 
Germany) with a set measurement position at 4.65 mm. Data 
were recorded using the Malvern Zetasizer software 7.11 (Malvern 
Instruments, Worcestershire). All samples were measured at 25 °C 
in 10% v/v DPBS (pH 7.4). PEG concentration in NPs was quantified 
using a colorimetric iodine complexing assay[47] and correlated 
with the exact gravimetrical NP content determined through 
lyophilization, as previously described by the group.[16] The molar NP 
concentration was calculated using Equation (1), where m is the NP 
mass determined through the iodine assay, ρNP is the density of the 
NPs (1.25 g cm−3),[48] dh is the hydrodynamic diameter of the NPs 
measured by DLS, NA is the Avogadro number, and V is the volume 








dh N Vρ pi
=  
×  (1)
Ligand content on NPs was quantified using a BCA assay, using 
Lys-Ang-I and Lys-Ang-II as standards, following the manufacturer’s 
instructions, and normalized to the molar PEG concentration to 
obtain the ligand density. Absorbance measurements were performed 
with a FLUOstar Omega microplate reader (BMG Labtech, Ortenber, 
Germany).
Intracellular Calcium Measurements: To quantify the AT1R response 
to the different NP formulations, a ratiometric Fura-2 Ca2+ chelator 
method[49] was used as previously described by the group.[2] In 
short, a rMC-suspension was incubated in Leibovitz medium (LM) 
supplemented with 5 × 10−6 m Fura-2AM, 0.05% Pluronic F-127, and 
2.5 × 10−3 m Probenecid (1 h, light protected, 50 rpm). The cells were 
washed with DPBS by centrifugation (2x, 200 g, 5 min) and adjusted to a 
count of either 2 or 1 million cells mL−1 (for IC50 or EC50 measurements, 
respectively) in LM with 2.5 × 10−3 m Probenecid. To determine EC50 
values (short stimulation) cells (90 000 cells) were injected on top of 
the samples (10 µL, 1 × 10−9 m to 300 × 10−6 m ligand concentration) 
and the resulting signal recorded immediately for 30 s per well using 
a FLUOstar Omega microplate reader. Filters used for excitation 
were 340/20 and 380/20 nm, and the emission was recorded with a 
510/20 nm bandpass filter. To determine IC50 values (long stimulation), 
samples (10 µL,1 × 10−9 m to 300 × 10−6 m ligand concentration) were 
incubated with 90 000 cells in a half-area microplate plate for 30 min. 
Afterward, an Ang-II solution (45 µL, 300 × 10−9 m) was injected on top 
of the samples and the calcium influx was measured as described above. 
0.1% Triton-X 100 or 0.1% Triton-X 100 with 45 × 10−3 m ethylene glycol-
bis(2-aminoethylether)-N,N,N´,N´-tetraacetic acid were used as control 
solutions to determine the maximal and minimal signal ratio (Rmax and 
Rmin). The intracellular calcium concentrations were calculated with an 
assumed Kd value of 255 × 10−9 m for the fura-2-calcium complex, after 
Grynkiewicz.[49] The maximum calcium signal (%) was plotted against 
the molar NP concentration, calculated after Equation (1), to allow 
comparison between formulations. Statistical significance was assessed 
by a Student’s t test using GraphPad Prism 6.0 (GraphPad Software Inc. 
La Jolla, CA).
Enzyme Kinetic Measurements: The Michaelis–Menten kinetics 
of the soluble form of ACE were determined using Ang-I bearing 
NP formulations as the substrate. To that end, the different NP 
formulations (ligand concentrations 10–200 × 10−6 m) were incubated 
with rabbit lung ACE (18 × 10−6 m) for different time periods (5, 15, 
30, 60, 90, and 120 min). The conversion over time of Ang-I to Ang-II 
on the particle corona was quantified by measuring the intracellular 
calcium influx generated by the AT1R stimulation by the hydrolyzed 
substrate, as described above. A range of known concentrations of 
Ang-II (1 × 10−9 m–300 × 10−6 m) were used as control samples in the 
assay to convert the measured calcium concentration ( × 10−9 m) to 
pmol of product. The velocity of the reaction (pmol min−1) at 15 min 
incubation time was plotted against the substrate concentration used 
in the assay to determine the Michaelis–Menten constant (Km) using 
GraphPad Prism 6.0. The catalytic constant (Kcat) was determined and 
the specificity constant (Kcat/Km) used to compare different substrates 
for one enzyme. A Student’s t test was performed with GraphPad Prism 
6.0 to assess statistical significance.
Flow Cytometry: To determine the uptake rates of the different 
NP formulations via flow cytometry, rMCs were seeded in 24-well 
plates (30 000 cells per well) and incubated over 48 h. Afterward, 
they were incubated for 45 min with CF647-labeled NP solutions 
(20 µg mL−1) in LM supplemented with 0.1% BSA. To inhibit the NP 
uptake, the cells were preincubated with either EXP3174 (1 × 10−3 m) 
or chlorpromazine, genistein, or cytochalasin D (25 × 10−6 m) in LM 
for 30 min prior to NP addition. Next, the cells were washed with 
DPBS, trypsinized and washed through centrifugation with DPBS (2x, 
200 g, 5 min, 4 °C). Finally, the NP-associated cell fluorescence was 
analyzed using a CyFlow Space flow cytometer (Sysmex Partec GmbH, 
Goerlitz, Germany) with FloMax software. A 638 nm red diode laser 
was used to excite, and a 675/30 bandpass filter was used to record 
fluorescence. Data were analyzed using Flowing software (Turku 
Centre for Biotechnology, Finland). The population of viable cells 
was gated, and the fluorescence geometrical mean was evaluated. 
GraphPad Prism 6.0 was used to asses statistical significance through 
a Student’s t-test.
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CLSM Analysis: To analyze NP uptake using CLSM, rMCs were seeded 
into 8-well Nunc Lab Tech II Chamber Slide systems (Thermo Fisher 
Scientific, Waltham, MA) (10 000 cells per well) and left to attach for 
24 h. After that, the cells were washed with DPBS and incubated with 
TAMRA-labeled NPs (20 µg mL−1) in LM supplemented with 0.1% BSA 
for 45 min. After the incubation period, the NP solutions were discarded, 
and the cells were washed with DPBS and stained fluorescently with 
CMDR (1x) for 5 min before fixing them with 4% paraformaldehyde in 
DPBS (10 min, r.t.). To inhibit the NP uptake, the cells were pretreated 
with EXP3174 (1 × 10−3 m) in LM with 0.1% BSA for 30 min prior to 
NP addition. Images were acquired with AIM4.2 software (Zeiss, Jena, 
Germany) using a Zeiss Axiovert 200 microscope with an LSM 510 
laser-scanning device using a 63x Plan-Apochromat (NA 1.4) objective. 
Fluorescence was excited with 543 and 633 nm He-Ne lasers and 
recorded with a 560–615 bandpass and a 650 longpass filter (for NP and 
cell fluorescence, respectively). The focal plane was set at 1.5 µm.
Calculation of the Distance between PEG Chains (D, Ds, and ds): The 
surface (S) that each PEG chain occupies on the NP was calculated 
after Gref et al.[12] using Equation (2) where MPEG is the molecular 
weight of the PEG chains and f is the mass fraction of PEG in the 
blends of PEG-PLA. Subsequently the distance between PEG chains was 
determined through Equation (3), assuming that S is a circular area,[50] 
and a homogeneous polymer distribution. The parameters used for the 
calculations are listed in Table S2 (Supporting Information). The RF was 
calculated as an indicator of the arrangement of the PEG chains on the 
NP surface with Equation (4) where the length of a PEG monomer is 
α = 0.35 nm and the number of monomers in one molecule (N) was 
determined by dividing the molecular weight of the PEG by the monomer 
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